Veru Inc.

About Veru Inc.

Veru Inc. is a biopharmaceutical company dedicated to developing and commercializing treatments for cardiometabolic and inflammatory diseases. Their mission is to address significant health issues such as muscle loss during weight loss therapy and to improve patient outcomes through innovative medicines.

Products & Services

Enobosarm:A novel, oral, selective androgen receptor modulator (SARM) aimed at preserving muscle mass in patients undergoing weight loss therapy with GLP-1 drugs, promoting high-quality weight loss.

Sabizabulin:A novel, oral broad anti-inflammatory agent developed to treat atherosclerotic coronary artery disease.

Specialties

Cardiometabolic diseases Inflammatory diseases Obesity drug programs Atherosclerosis treatment Selective androgen receptor modulators (SARM) Anti-inflammatory agents

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 25200000 MR: - FA: $25.2 million FAN: 25200000	D: 2025-10-30 FD: 2025-10-30	2 investors
2	RT: Public Offering T: - FT: Public Offering	A: 33000000 MR: - FA: approximately $33 million FAN: 33000000	D: 2023-12-14 FD: 2023-12-14	2 investors
3	RT: Common Stock Purchase Agreement T: - FT: Common Stock Purchase Agreement	A: 100000000 MR: - FA: up to $100 million FAN: 100000000	D: 2023-05-03 FD: 2023-05-03	1 investors

Public Offering Latest

2025-10-30

$25.2M

2 investors (Pro only)

Public Offering 2023-12-14

$33.0M

Common Stock Purchase Agreement 2023-05-03

$100.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mitchell Steiner

Chairman, President, and Chief Executive Officer

LinkedIn (Pro only)

H

Harry Fisch

Vice Chairman, Chief Corporate Officer

LinkedIn (Pro only)

M

Michele Greco

Chief Financial Officer and Chief Administrative Officer

K

K. Gary Barnette

Chief Scientific Officer

G

Gary Bird

Executive Vice President - Quality and Regulatory Affairs

S

Samuel Fisch

Executive Director, Investor Relations & Corporate Communications

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Veru Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised